The summary below is from the full report titled “Cost-Effectiveness of Preventive Strategies for Women with a BRCA1 or a BRCA2 Mutation.” It is in the 21 March 2006 issue of Annals of Internal Medicine (volume 144, pages 397-406). The authors are K. Anderson, J.S. Jacobson, D.F. Heitjan, J. Graff Zivin, D. Hershman, A.I. Neugut, and V.R. Grann.
The Cost-Effectiveness of Preventive Strategies for Breast and Ovarian Cancer for Women with BRCA1 or BRCA2 Mutations. Ann Intern Med. 2006;144:I–40. doi: https://doi.org/10.7326/0003-4819-144-6-200603210-00002
Download citation file:
Published: Ann Intern Med. 2006;144(6):I-40.
Healthcare Delivery and Policy, Hematology/Oncology.
Results provided by:
Copyright © 2020 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use